Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Index level data represents a snapshot of market values at a given time. This explanation covers how levels are computed and used in analysis.
24,561 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A WWII pivot from battleships to aircraft carriers and submarines reshaped global power and markets. Today’s investor...
A fintech just reported a blowout quarter, yet the stock still looks cheap to patient investors. This analysis breaks...
The Trade Desk surged after a large insider purchase by its CEO, lifting the stock among S&P 500 movers as Palantir a...
A major AI feature sparked controversy in the writing world. Grammarly paused its 'Expert Review' tool after authors ...
As voice interfaces become a staple in shopping, SoundHound AI could rise as a key AI infrastructure layer. This arti...
Retail investors are leading gold ETF inflows as institutions tilt back toward Bitcoin through regulated ETFs, creati...
Two Kalshi veterans are raising up to $35 million for a new prediction-market VC fund called 5c(c) Capital, backed by...
A keynote from Nvidia's founder signals a major shift for AI hardware and software. This could change the game for Nv...
The latest weekly data show the number people getting unemployment dropping to a 2½-year low, as initial claims ease ...
Nvidia sits at the center of AI, and May 20 earnings looms large. This guide breaks down whether you should Nvidia st...
A new market dynamic is taking hold: memory pricing and capex discipline are steering the current semiconductor upcyc...